Buy Aurobindo Pharma, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Aurobindo Pharma is a buy whether markets are up or they are sideways or consolidating. Aurobindo Pharma itself has made new highs a few days ago, it consolidated for some days and that is normal. There is a breakout which is imminent and that breakout could easily take it to lifetime highs again. So, if not anything else we talked about the correction in pharma and Aurobindo Pharma is the first sign that may be eventually this correction could be shallow and getting over."

At 10:52 hrs Aurobindo Pharma was quoting at Rs 1,358.75, up Rs 9.15, or 0.68 percent. It has touched an intraday high of Rs 1,375 and an intraday low of Rs 1,355.40.